GLP-1s in Your Chair: What the New Weight and Diabetes Medications Mean for Your Hygiene Appointments
GLP-1 receptor agonists -- semaglutide, tirzepatide, liraglutide -- have transformed diabetes and obesity management, and that patient is already in your chair. Emerging 2025 research reveals a bidirectional relationship: periodontopathic bacteria can degrade GLP-1 activity, while GLP-1 patients present with distinct oral profiles including xerostomia, elevated caries risk, and enamel erosion.
This course equips dental hygienists to recognize GLP-1-related oral findings, build individualized preventive protocols, and navigate the oral systemic conversation -- including how periodontal care itself may positively influence GLP-1 outcomes.
Learning Objectives
* Identify the mechanism of action of GLP-1 receptor agonists and their prevalence
* Describe the bidirectional relationship between periodontitis and GLP-1 pathways
* Recognize oral manifestations: xerostomia, caries risk, enamel erosion, altered biofilm
* Develop individualized preventive and maintenance protocols for patients on GLP-1 therapy
* Apply oral-systemic communication strategies and coordinate interdisciplinary care
